CAMBRIDGE, Mass., Sept. 24, 2018 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company
focused on the development of curative therapeutics using CRISPR/Cas9 technology, will participate in the following upcoming
healthcare conferences in October:
Monday, October 1, 2018
Cantor Fitzgerald Healthcare Conference
Location: New York, NY
Time: 4:40pm ET
Tuesday, October 2, 2018
Leerink Partners Roundtable Series: Rare Disease & Oncology
Location: New York, NY
Time: 10:30am ET
Tuesday, October 9, 2018
Chardan Genetic Medicines Conference
Location: New York, NY
Time: 1:30pm ET
A live webcast of Intellia’s presentations will be accessible through the Events and Presentations page of the Investor
Relations section of the company’s website at www.intelliatx.com. To access the webcasts, please log on to the Intellia website
approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay
of the webcasts will be available on Intellia’s website for approximately 14 days following each conference.
About Intellia Therapeutics
Intellia Therapeutics is a leading genome editing company focused on developing proprietary, curative therapeutics using the
CRISPR/Cas9 system. Intellia believes the CRISPR/Cas9 technology has the potential to transform medicine by permanently editing
disease-associated genes in the human body with a single treatment course, and through improved cell therapies that can treat
cancer and immunological diseases by replacing patients’ diseased cells. The combination of deep scientific, technical and clinical
development experience, along with its leading intellectual property portfolio, puts Intellia in a unique position to unlock broad
therapeutic applications of the CRISPR/Cas9 technology and create a new class of therapeutic products. Learn more about Intellia
Therapeutics and CRISPR/Cas9 at intelliatx.com and follow us on Twitter @intelliatweets.
Investor
Contact:
Lindsey Trickett
Vice President, Investor Relations
+1 857-285-6211
lindsey.trickett@intelliatx.com
Media Contact:
Jennifer Mound Smoter
Senior Vice President, External Affairs & Communications
+1 857-706-1071
jenn.smoter@intelliatx.com
